eMedicine Specialties > Dermatology > Psychocutaneous Diseases

Delusions of Parasitosis

Author: Noah S Scheinfeld, MD, JD, FAAD, Assistant Clinical Professor, Department of Dermatology, Columbia University; Consulting Staff, Department of Dermatology, St Luke's Roosevelt Hospital Center, Beth Israel Medical Center, New York Eye and Ear Infirmary; Private Practice
Contributor Information and Disclosures

Updated: Feb 12, 2008

Introduction

Background

Delusions of parasitosis (DP) manifest in the patient's firm belief that he or she has pruritus due to an infestation with insects. Patients may present with clothing lint, pieces of skin, or other debris contained in plastic wrap, on adhesive tape, or in matchboxes. They typically state that these contain the parasites; however, these collections have no insects or parasites. This presentation is called the matchbox sign, or what the authors term the "Saran-wrap sign."

The patients have no obvious cognitive impairment, and abnormal organic factors are absent. True infestations and primary systemic diseases that cause pruritus are not involved. Primary skin lesions are not present. Physical examination may reveal no lesions, but only linear erosions with crusts, prurigo nodularis, and/or ulcers.

The classification of DP is complicated. It is considered primarily a monosymptomatic hypochondriacal psychosis and has been associated with schizophrenia, obsessional states, bipolar disorder, depression, and anxiety disorders. DP occurs primarily in white middle-aged or older women, although it has been reported in all age groups and in men.

Medscape Resource Centers for Schizophrenia, Bipolar Disorder, Depression, and Anxiety Disorders may provide helpful additional information.

Savely et al1  introduced the term Morgellon disease to describe a condition characterized by fibers attached to the skin. The entity appears to be little more than a new designation for DP. Koblenzer2  and Waddell and Burke3 have discussed the utility of the term, with Murase et al4 finding the term useful for building a therapeutic alliance with patients with DP. The Centers for Disease Control and Prevention is currently investigating Morgellon disease.5

William Harvey6 of the Morgellons Research Foundation Medical Advisory Board states the following:

All patients with Morgellons carry elevated laboratory proinflammatory markers, elevated insulin levels, and verifiable serologic evidence of 3 bacterial pathogens. They also show easily found physical markers such as peripheral neuropathy, delayed capillary refill, abnormal Romberg’s sign, decreased body temperature, and tachycardia. Most importantly they will improve, and most recover on antibiotics directed at the above pathogens.

The author of this article has not found reliable data to back up William Harvey's claims, but they are included here to comprehensively address this issue.

Walling and Swick7 suggest abandoning 3 the diagnostic terms trichotillomania, delusions of parasitosis, and neurotic excoriation, which they believe have become barriers to treatment. Instead, they suggest using the alternative patient-centered nomenclature of neuromechanical alopecia, pseudoparasitic dysesthesia, and (simply) excoriation. For additional information on the other topics mentioned, see Trichotillomania and Neurotic Excoriations.

Pathophysiology

The cause of DP is unknown. It appears related to neurochemical pathology. This concept is underlined by its induction by psychoactive agents (eg, amphetamines, cocaine, and methylphenidate) and its coincidence with depression, schizophrenia, social isolation, and sensory impairment.

Frequency

United States

The exact prevalence of DP is unknown.

International

The exact prevalence of DP is unknown.

Mortality/Morbidity

The literature includes one report of suicide in a 40-year-old man with DP.8

Race

DP appears to be more common in whites than in people of other races.

Sex

DP occurs primarily in white middle-aged or older women, although it has been reported in all age groups and in men. The female-to-male ratio is approximately 2:1. More specifically, this ratio is 1:1 in people younger than 50 years and 3:1 in those older than 50 years.

Age

This disease is more common in middle-aged and elderly persons than in others. The male-to-female ratio is 1:1 in people younger than 50 years and 3:1 in those older than 50 years.

Clinical

History

Patients must be queried about their symptoms, the duration of symptoms, and their belief about the etiology. Notably, Goddard9 has described a seasonality to DP.

The diagnosis and treatment of DP can be an involved clinical activity. Patients with DP can resist suggestions that their condition is psychiatric rather than physical and refuse referrals for psychiatric care. In fact, in 35% of patients, the belief of infestation is unshakable. In approximately 12% of patients, the delusion of infestation is shared by a significant other. This phenomenon is known as folie à deux (eg, craziness for 2) or folie partagé (ie, shared delusions). Variations in this are the conviction that a child, a spouse, or a pet is infested.

DP is a monosymptomatic psychosis, a type of psychopathology relatively distinct from the remainder of the personality. If the condition has a defined pathologic or external cause (eg, scabies) it is not truly DP. In investigating the history of a patient with such suspected delusions, other causes of itch must be investigated. To diagnose this condition, true infestations (eg, scabies), pediculosis, and primary systemic causes of pruritus must be excluded. Examples include hepatitis, HIV infection, dermatitis herpetiformis, thyroid disease, anemia, renal dysfunction, neurologic dysfunction, and lymphoma.

DP is distinct from formication. Formication involves the cutaneous sensation of crawling, biting, and stinging. Formication does not involve the fixed conception that skin sensations are induced by parasites. Patients with this condition can accept proof that they do not have an infestation. Many cases of formication remain idiopathic.

Mimics of DP

Other forms of psychiatric illness can mimic DP. Such psychiatric illnesses are accompanied by signs of mental illness.

For example, patients with schizophrenia may think they are being attacked by insects as a manifestation of their paranoia.

A type of severe depression termed psychotic depression may cause the patient to believe he or she is contaminated or "dirty" because of insect infestation. Such a patient may have a depressed mood and a sense of helplessness, hopelessness, worthlessness, or excessive guilt. Often, these feelings are obvious at clinical presentation.10

Drug-induced delusions of parasitosis have been reported during treatment for Parkinson disease.11

Steinert and Studemund12 reported a 45-year-old man who did not have a history of psychological pathology, who, after ingesting ciprofloxacin to treat an infection, was overcome with acute delusional parasitosis. He stopped taking the ciprofloxacin, and the DP resolved altogether without utilization of an antipsychotic agent. Cases in which an etiology is defined are best classified as secondary DP.

Guarneri et al13 noted a patient who was thought to have DP but who, in fact, had infestation with Limothrips cerealium; they termed the condition pseudo-delusory syndrome (ie, infestation with an uncommon insect).

Ghaffari-Nejad and Toofani14  noted a case of secondary DP in a patient with major depressive disorder who had delusions of oral parasitosis; the patient sensed lizards and small organisms in her mouth.

Physical

Patients with DP create their skin rash. They can present with no findings, erosions or ulcers with or without crusts or prurigo nodularis. They may evidence a dermatitis related to attempted treatments, which may include irritating or corrosive cleansers or harsh abrasive devices.

More on Delusions of Parasitosis

Overview: Delusions of Parasitosis
Differential Diagnoses & Workup: Delusions of Parasitosis
Treatment & Medication: Delusions of Parasitosis
Follow-up: Delusions of Parasitosis
References

References

  1. Savely VR, Leitao MM, Stricker RB. The mystery of Morgellons disease: infection or delusion?. Am J Clin Dermatol. 2006;7(1):1-5. [Medline].

  2. Koblenzer CS. The challenge of Morgellons disease. J Am Acad Dermatol. Nov 2006;55(5):920-2. [Medline].

  3. Waddell AG, Burke WA. Morgellons disease?. J Am Acad Dermatol. Nov 2006;55(5):914-5. [Medline].

  4. Murase JE, Wu JJ, Koo J. Morgellons disease: a rapport-enhancing term for delusions of parasitosis. J Am Acad Dermatol. Nov 2006;55(5):913-4. [Medline].

  5. Marris E. Mysterious 'Morgellons disease' prompts US investigation. Nat Med. Sep 2006;12(9):982. [Medline].

  6. Harvey WT. Morgellons disease. J Am Acad Dermatol. Apr 2007;56(4):705-6. [Medline].

  7. Walling HW, Swick BL. Psychocutaneous syndromes: a call for revised nomenclature. Clin Exp Dermatol. May 2007;32(3):317-9. [Medline].

  8. Monk BE, Rao YJ. Delusions of parasitosis with fatal outcome. Clin Exp Dermatol. Jul 1994;19(4):341-2. [Medline].

  9. Goddard J. Seasonality of delusions of parasitosis. J Agromedicine. 2003;9(1):23-6. [Medline].

  10. Koo J, Lee CS. Delusions of parasitosis. A dermatologist's guide to diagnosis and treatment. Am J Clin Dermatol. 2001;2(5):285-90. [Medline].

  11. Swick BL, Walling HW. Drug-induced delusions of parasitosis during treatment of Parkinson's disease. J Am Acad Dermatol. Dec 2005;53(6):1086-7. [Medline].

  12. Steinert T, Studemund H. Acute delusional parasitosis under treatment with ciprofloxacin. Pharmacopsychiatry. Jul 2006;39(4):159-60. [Medline].

  13. Guarneri F, Guarneri C, Mento G, Ioli A. Pseudo-delusory syndrome caused by Limothrips cerealium. Int J Dermatol. Mar 2006;45(3):197-9. [Medline].

  14. Ghaffari-Nejad A, Toofani K. Delusion of oral parasitosis in a patient with major depressive disorder. Arch Iran Med. Jan 2006;9(1):76-7. [Medline].

  15. Scheinfeld N. Delusions of parasitiosis: a case with a review of its course and treatment. Skinmed. Nov-Dec 2003;2(6):376-8. [Medline].

  16. Wenning MT, Davy LE, Catalano G, Catalano MC. Atypical antipsychotics in the treatment of delusional parasitosis. Ann Clin Psychiatry. Sep-Dec 2003;15(3-4):233-9. [Medline].

  17. Reichenberg JS, Magid M, Drage LA. A cure for delusions of parasitosis. J Eur Acad Dermatol Venereol. Nov 2007;21(10):1423-4. [Medline].

  18. Rocha FL, Hara C. Aripiprazole in delusional parasitosis: Case report. Prog Neuropsychopharmacol Biol Psychiatry. Apr 13 2007;31(3):784-6. [Medline].

  19. Szepietowski JC, Salomon J, Hrehorów E, Pacan P, Zalewska A, Sysa-Jedrzejowska A. Delusional parasitosis in dermatological practice. J Eur Acad Dermatol Venereol. Apr 2007;21(4):462-5. [Medline].

  20. Elmer KB, George RM, Peterson K. Therapeutic update: use of risperidone for the treatment of monosymptomatic hypochondriacal psychosis. J Am Acad Dermatol. Oct 2000;43(4):683-6. [Medline].

  21. Friedmann AC, Ekeowa-Anderson A, Taylor R, Bewley A. Delusional parasitosis presenting as folie à trois: successful treatment with risperidone. Br J Dermatol. Oct 2006;155(4):841-2. [Medline].

  22. Meehan WJ, Badreshia S, Mackley CL. Successful treatment of delusions of parasitosis with olanzapine. Arch Dermatol. Mar 2006;142(3):352-5. [Medline].

  23. van Vloten WA. Pimozide: use in dermatology. Dermatol Online J. Mar 2003;9(2):3. [Medline].

  24. Lim GC, Chen YF, Liu L, Huang SC, Lin KK, Hsiao CH. Camphor-related self-inflicted keratoconjunctivitis complicating delusions of parasitosis. Cornea. Dec 2006;25(10):1254-6. [Medline].

  25. Aw DC, Thong JY, Chan HL. Delusional parasitosis: case series of 8 patients and review of the literature. Ann Acad Med Singapore. Jan 2004;33(1):89-94. [Medline].

  26. Bourée P, Benattar B, Périvier S. Ekbom syndrome or delusional parasitosis. Rev Prat. 2007 Mar 31;57(6):585-9. Review[Medline].

  27. Donabedian H. Delusions of Parasitosis. Clin Infect Dis. Oct 19 2007;45(11):[Medline].

  28. Edison KE, Slaughter JR, Hall RD. Psychogenic parasitosis: a therapeutic challenge. Mo Med. Mar-Apr 2007;104(2):132-7; quiz 137-8. [Medline].

  29. Elkan D. Morgellons disease: real or delusion?. New Scientist. Sep 15 2007;195 (2621):46-9.

  30. Freudenmann RW, Schönfeldt-Lecuona C. Delusional parasitosis: treatment with atypical antipsychotics. Ann Acad Med Singapore. Jan 2005;34(1):141-2; author reply 142. [Medline].

  31. Gould WM, Gragg TM. Delusions of parasitosis. An approach to the problem. Arch Dermatol. Dec 1976;112(12):1745-8. [Medline].

  32. Krauseneck T, Soyka M. Delusional parasitosis associated with pemoline. Psychopathology. Mar-Apr 2005;38(2):103-4. [Medline].

  33. Krishnan A, Koo J. Psyche, opioids, and itch: therapeutic consequences. Dermatol Ther. Jul-Aug 2005;18(4):314-22. [Medline].

  34. Le L, Gonski PN. Delusional parasitosis mimicking cutaneous infestation in elderly patients. Med J Aust. Aug 18 2003;179(4):209-10. [Medline].

  35. Lepping P, Russell I, Freudenmann RW. Antipsychotic treatment of primary delusional parasitosis: systematic review. Br J Psychiatry. Sep 2007;191:198-205. [Medline].

  36. Nicolato R, Corrêa H, Romano-Silva MA, Teixeira AL Jr. Delusional parasitosis or Ekbom syndrome: a case series. Gen Hosp Psychiatry. Jan-Feb 2006;28(1):85-7. [Medline].

  37. Paquette M. Morgellons: disease or delusions?. Perspect Psychiatr Care. Apr 2007;43(2):67-8. [Medline].

  38. Tran TM, Browning J, Dell ML. Psychosis with paranoid delusions after a therapeutic dose of mefloquine: a case report. Malar J. 2006;5:74. [Medline].

  39. Wilson FC, Uslan DZ. Delusional parasitosis. Mayo Clin Proc. Nov 2004;79(11):1470. [Medline].

  40. Zanol K, Slaughter J, Hall R. An approach to the treatment of psychogenic parasitosis. Int J Dermatol. Jan 1998;37(1):56-63. [Medline].

Further Reading

Keywords

DP, DOP, insect infestation, matchbox sign, monosymptomatic hypochondriacal psychosis, delusion of infestation, delusional parasitosis, delusional infestation, folie à deux, folie partagé, morgellons disease.

Contributor Information and Disclosures

Author

Noah S Scheinfeld, MD, JD, FAAD, Assistant Clinical Professor, Department of Dermatology, Columbia University; Consulting Staff, Department of Dermatology, St Luke's Roosevelt Hospital Center, Beth Israel Medical Center, New York Eye and Ear Infirmary; Private Practice
Noah S Scheinfeld, MD, JD, FAAD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

Medical Editor

Franklin Flowers, MD, Chief, Division of Dermatology, Professor, Department of Medicine and Otolaryngology, University of Florida College of Medicine
Franklin Flowers, MD is a member of the following medical societies: American College of Mohs Micrographic Surgery and Cutaneous Oncology, Lipoplasty Society of North America, Southwest Pediatric Nephrology Study Group, Southwestern Oncology Group, Southwestern Surgical Congress, Special Operations Medical Association, State Medical Society of Wisconsin, Swedish Medical Association, Sydenham Society, Tennessee Medical Association, Tennessee Radiological Society, Texas Medical Association, Texas Pediatric Society, Texas Society of Plastic Surgeons, Undersea and Hyperbaric Medical Society, Uniformed Services Academy of Family Physicians, United States and Canadian Academy of Pathology, United States Pharmacopeial Convention, US Virgin Islands Medical Society, Utah Medical Association, Vermont State Medical Society, Vestibular Disorders Association, Virginia Society of Otolaryngology-Head and Neck Surgery, West Virginia State Medical Association, Western Occupational and Environmental Medical Association, Western Orthopaedic Association, Western Section American Urological Association, Western Surgical Association, Wilderness Medical Society, World Association of Societies of Pathology and Laboratory Medicine, World Medical Association, World Society for Stereotactic and Functional Neurosurgery, and Wyoming Medical Society
Disclosure: Nothing to disclose.

Pharmacy Editor

David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Director, Division of Dermatology, Scott and White Clinic; Director Dermatology Residency Training Program, Scott and White Clinic
David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa
Disclosure: 3M Pharmaceutical Grant/research funds Other; Graceway Pharmaceuticals Grant/research funds Other

Managing Editor

Jeffrey Meffert, MD, Assistant Clinical Professor of Dermatology, University of Texas Health Science Center-San Antonio
Jeffrey Meffert, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

RELATED EMEDICINE ARTICLES
Patient Education
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.